Literature DB >> 19758659

Partial nephrectomy after previous radio frequency ablation: the National Cancer Institute experience.

Keith J Kowalczyk1, H Brooks Hooper, W Marston Linehan, Peter A Pinto, Bradford J Wood, Gennady Bratslavsky.   

Abstract

PURPOSE: Development of new renal tumors or recurrence after radio frequency ablation not amendable for repeat ablation presents a difficult therapeutic dilemma. We report on the outcomes of partial nephrectomy on kidneys previously treated with radio frequency ablation.
MATERIALS AND METHODS: We performed a chart review of 13 patients who underwent 16 attempted partial nephrectomies following radio frequency ablation. Hospital records and operative reports were reviewed for demographic data, perioperative data and outcomes. The outcomes of the present series were compared to historical controls of published studies in similar patient populations.
RESULTS: No cases were converted to radical nephrectomy. Median time from radio frequency ablation to surgery was 2.75 years (range 1 to 7.1). A median of 7 tumors (range 2 to 40) were removed with a median estimated blood loss of 1,500 ml (range 500 to 3,500) and a median operative time of 7.8 hours (range 5 to 10.7). Operative notes commented on the presence of severe fibrosis in the operative field in 12 of 16 cases (75%). There was a modest but statistically significant decrease in renal function. Partial nephrectomy after radio frequency ablation had a higher reoperation rate compared to other series of primary or repeat partial nephrectomies but had the lowest rate of vascular or visceral injuries.
CONCLUSIONS: Partial nephrectomy on kidneys previously treated with radio frequency ablation is a technically challenging but feasible procedure. Residual or metachronous disease after radio frequency ablation may be salvaged with partial nephrectomy with a modest decrease in renal function. A trend toward a higher chance of reoperation and urine leak after partial nephrectomy after radio frequency ablation may be useful information for the planning and discussion of treatment decisions.

Entities:  

Mesh:

Year:  2009        PMID: 19758659      PMCID: PMC3404484          DOI: 10.1016/j.juro.2009.07.064

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  20 in total

1.  Percutaneous radio frequency ablation of small renal tumors: initial results.

Authors:  Christian P Pavlovich; McClellan M Walther; Peter L Choyke; Stephen E Pautler; Richard Chang; W Marston Linehan; Bradford J Wood
Journal:  J Urol       Date:  2002-01       Impact factor: 7.450

2.  Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience.

Authors:  J C Herring; E G Enquist; A Chernoff; W M Linehan; P L Choyke; M M Walther
Journal:  J Urol       Date:  2001-03       Impact factor: 7.450

3.  Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors.

Authors:  Inderbir S Gill; Louis R Kavoussi; Brian R Lane; Michael L Blute; Denise Babineau; J Roberto Colombo; Igor Frank; Sompol Permpongkosol; Christopher J Weight; Jihad H Kaouk; Michael W Kattan; Andrew C Novick
Journal:  J Urol       Date:  2007-05-11       Impact factor: 7.450

4.  Salvage partial nephrectomy for hereditary renal cancer: feasibility and outcomes.

Authors:  Gennady Bratslavsky; Jack J Liu; Aaron D Johnson; Sunil Sudarshan; Peter L Choyke; W Marston Linehan; Peter A Pinto
Journal:  J Urol       Date:  2007-11-13       Impact factor: 7.450

5.  Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis.

Authors:  David A Kunkle; Robert G Uzzo
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

Review 6.  Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review.

Authors:  David A Kunkle; Brian L Egleston; Robert G Uzzo
Journal:  J Urol       Date:  2008-02-20       Impact factor: 7.450

7.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

8.  Feasibility and outcomes of repeat partial nephrectomy.

Authors:  Aaron Johnson; Sunil Sudarshan; Jack Liu; W Marston Linehan; Peter A Pinto; Gennady Bratslavsky
Journal:  J Urol       Date:  2008-05-15       Impact factor: 7.450

9.  Surgical salvage of renal cell carcinoma recurrence after thermal ablative therapy.

Authors:  Carvell T Nguyen; Brian R Lane; Jihad H Kaouk; Nicholas Hegarty; Inderbir S Gill; Andrew C Novick; Steven C Campbell
Journal:  J Urol       Date:  2008-05-15       Impact factor: 7.450

10.  Percutaneous and laparoscopic cryoablation of small renal masses.

Authors:  David S Finley; Shawn Beck; Geoffrey Box; William Chu; Leslie Deane; Duane J Vajgrt; Elspeth M McDougall; Ralph V Clayman
Journal:  J Urol       Date:  2008-06-11       Impact factor: 7.450

View more
  27 in total

Review 1.  Management of locally recurrent kidney cancer.

Authors:  Eric A Singer; Gennady Bratslavsky
Journal:  Curr Urol Rep       Date:  2010-02       Impact factor: 3.092

Review 2.  Long-term management of bilateral, multifocal, recurrent renal carcinoma.

Authors:  Gennady Bratslavsky; W Marston Linehan
Journal:  Nat Rev Urol       Date:  2010-05       Impact factor: 14.432

3.  Feasibility and outcomes of partial nephrectomy for resection of at least 20 tumors in a single renal unit.

Authors:  Amaka T Fadahunsi; Thomas Sanford; W Marston Linehan; Peter A Pinto; Gennady Bratslavsky
Journal:  J Urol       Date:  2010-11-12       Impact factor: 7.450

Review 4.  Molecular genetics and clinical features of Birt-Hogg-Dubé syndrome.

Authors:  Laura S Schmidt; W Marston Linehan
Journal:  Nat Rev Urol       Date:  2015-09-01       Impact factor: 14.432

Review 5.  Percutaneous ablation in the kidney.

Authors:  Aradhana M Venkatesan; Bradford J Wood; Debra A Gervais
Journal:  Radiology       Date:  2011-11       Impact factor: 11.105

6.  Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes.

Authors:  Nick W Liu; Kiranpreet Khurana; Sunil Sudarshan; Peter A Pinto; W Marston Linehan; Gennady Bratslavsky
Journal:  J Urol       Date:  2010-03-17       Impact factor: 7.450

7.  Renal function and oncologic outcomes in nephron sparing surgery for renal masses in solitary kidneys.

Authors:  Daniel J Lee; Greg Hruby; Mitchell C Benson; James M McKiernan
Journal:  World J Urol       Date:  2010-07-11       Impact factor: 4.226

8.  Kidney cancer: Is incomplete renal ablation linked to tumour progression?

Authors:  Brian Shuch; W Marston Linehan
Journal:  Nat Rev Urol       Date:  2012-08-28       Impact factor: 14.432

Review 9.  [Ablative therapy of small renal masses].

Authors:  M C Kriegmair; N Wagener; S J Diehl; N Rathmann
Journal:  Urologe A       Date:  2018-03       Impact factor: 0.639

Review 10.  Diagnosis and management of BHD-associated kidney cancer.

Authors:  Lambros Stamatakis; Adam R Metwalli; Lindsay A Middelton; W Marston Linehan
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.